EnRu
Let’s discuss

Cardiology: early detection of cardiovascular risks

Our sensors allow quick and cost-effective detection of heart risks.

Cardiology: early detection <span>of&nbsp;cardiovascular risks</span>

Overview

Cardiovascular diseases, the leading global cause of death, underscore the vital need for early detection to enable prevention and timely intervention.

Contact us

Cardiovascular diseases (CVDs) are the top cause of death globally, claiming millions annually. The rise in heart attacks, strokes, and hypertension highlights the need for early detection. This allows healthcare providers to implement preventive measures and reduce the impact of these diseases.

The Nucleotica platform offers ctDNA and analysis for accurate insights into cardiovascular health. It helps identify genetic risks, enabling early diagnosis and timely intervention for better patient outcomes.

Nucleotica
01

Detection SNPs of high risk.

The Nucleotica platform provides high risk SNP (Single Nucleotide Polymorphism) analysis and offers a non-invasive, real-time window into cardiovascular health, enabling healthcare providers to predict the cardiovascular diseases, even before clinical symptoms manifest, and to create personalized care plans tailored to the genetic profile of each patient.

Early detection.

Detecting SNPs of high risk as early as possible can lead to faster diagnosis and more effective treatment strategies, significantly improving patient outcomes.

Real-time monitoring.

Tracking SNPs offers insights into cardio-vascular health, trombosis predisposition and dramatic changes in lipid metabolism.

Genetic risk.

SNP analysis identifies mutations and variations associated with heart disease risk, providing physicians with valuable information to tailor prevention and treatment plans.

Targeted treatment.

Based on genetic risk profiles, healthcare providers can recommend specific lifestyle changes, medications, or interventions aimed at mitigating the risks associated with cardiovascular diseases.
02

Compact and portable design.

One of the key advantages of the Nucleotica platform is its portability. Traditional cardiovascular diagnostic tools are often large, expensive, and require a highly controlled lab environment. In contrast, our device is designed for ease of use and can be operated in clinical settings, remote areas, or even mobile health initiatives.

Mobile health.

The platform's compact design enables mobile health solutions, letting healthcare professionals conduct cardiovascular risk assessments in underserved areas.

Field-ready testing.

The ease of use of the platform allows non-specialized medical personnel to independently conduct testing outside of clinics (sanatoriums, wellness centers).

Impact on Healthcare

The Nucleotica platform can impact healthcare by enabling early detection for cardiovascular diseases.

Early intervention strategies.

Identifying cardiovascular risks early enables timely intervention, enhancing patient outcomes and lessening healthcare burdens. Real-time monitoring of ctDNA and genetic factors allows providers to act before conditions worsen, lowering the risk of severe complications.

Personalized risk assessments.

By integrating SNP analysis into cardiovascular assessments, the platform allows for the creation of personalized health plans. Patients are assessed based on both their genetic predisposition and real-time blood biomarkers, ensuring a targeted approach to treatment and prevention.

Reducing healthcare costs.

Early detection and proactive management of cardiovascular health can significantly reduce long-term healthcare costs. Preventing severe cardiovascular events and complications leads to fewer hospital admissions, lower medical bills, and improved quality of life for patients.

Applications

The versatility of the Nucleotica platform makes it ideal for a wide range of applications in cardiology.

Contact us
01
Proactive cardiovascular risk screening in primary care settings.

Proactive cardiovascular risk screening in primary care settings.

Primary care physicians can use the platform for regular screening of patients at risk for cardiovascular diseases, such as those with a family history of heart disease, high cholesterol, or hypertension.
02
Continuous monitoring of patients.

Continuous monitoring of patients.

Patients with existing cardiovascular conditions can benefit from continuous monitoring of their cell-free DNA levels using liquid biopsy. For example, the assessment of cfDNA may help predict the severity of acute myocardial infarction and diagnose heart transplant rejection.
03
Mobile health initiatives targeting underserved populations.

Mobile health initiatives targeting underserved populations.

The portability of the Nucleotica platform makes it ideal for use in mobile health programs, reaching populations in rural or underserved areas where access to specialized cardiovascular diagnostics may be limited.
04
Global health outreach.

Global health outreach.

In low-resource regions, mobile units equipped with the platform can deliver early diagnostics to people who otherwise wouldn't have access to heart health screenings.
05
Preventive care.

Preventive care.

Early risk assessments allow doctors to intervene before symptoms arise, offering tailored lifestyle recommendations and preventive treatments.

Nucleotica

Why choose the Nucleotica platform for cardiovascular risk detection?

Contact us

Accurate detection.

Our platform offers unmatched precision in identifying cardiovascular risks before symptoms appear, enabling healthcare providers to act proactively.

Portability.

Its compact, portable design allows real-time testing in virtually any setting—from hospitals to remote locations—ensuring that heart health is accessible to all.

Personalized care.

Through SNP analysis, our platform provides personalized insights into genetic predispositions, enabling tailored prevention and treatment strategies for each patient.

Cost-effective.

By reducing the need for expensive infrastructure and offering fast, affordable diagnostics, our platform is an economical choice for both healthcare providers and patients.

Impactful healthcare.

With the ability to detect risks early, reduce healthcare costs, and improve patient outcomes, the Nucleotica platform is a vital tool in the fight against cardiovascular diseases.

Contact us

Reach out to start your next innovation today.